Harvey Bialy

559 total citations
48 papers, 427 citations indexed

About

Harvey Bialy is a scholar working on Molecular Biology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Harvey Bialy has authored 48 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Genetics and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Harvey Bialy's work include Biotechnology and Related Fields (7 papers), Bacteriophages and microbial interactions (3 papers) and Bacterial Genetics and Biotechnology (3 papers). Harvey Bialy is often cited by papers focused on Biotechnology and Related Fields (7 papers), Bacteriophages and microbial interactions (3 papers) and Bacterial Genetics and Biotechnology (3 papers). Harvey Bialy collaborates with scholars based in United States, Mexico and Sweden. Harvey Bialy's co-authors include Gianpiero Sironi, Richard Calendar, Gunnar Lindahl, Clarence Colby, H. Lozeron, Roberto P. Stock, Tokio Kogoma, Martin L. Pato, B. Waggoner and J. M. Papadimitriou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Biotechnology and Journal of Virology.

In The Last Decade

Harvey Bialy

44 papers receiving 378 citations

Peers

Harvey Bialy
Bahram Arezi United States
Vincent van Dam Netherlands
Susan L. Harlocker United States
Joseph A. Bogan United States
James L. Hodnett United States
Paige Pardington United States
Anne E. Stellwagen United States
Harvey Bialy
Citations per year, relative to Harvey Bialy Harvey Bialy (= 1×) peers Oleg Gimadutdinow

Countries citing papers authored by Harvey Bialy

Since Specialization
Citations

This map shows the geographic impact of Harvey Bialy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harvey Bialy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harvey Bialy more than expected).

Fields of papers citing papers by Harvey Bialy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harvey Bialy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harvey Bialy. The network helps show where Harvey Bialy may publish in the future.

Co-authorship network of co-authors of Harvey Bialy

This figure shows the co-authorship network connecting the top 25 collaborators of Harvey Bialy. A scholar is included among the top collaborators of Harvey Bialy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harvey Bialy. Harvey Bialy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stock, Roberto P. & Harvey Bialy. (2003). The sigmoidal curve of cancer. Nature Biotechnology. 21(1). 13–14. 21 indexed citations
2.
Bialy, Harvey. (2000). Good faith gone bad. Nature Biotechnology. 18(11). 1123–1123. 1 indexed citations
3.
Bialy, Harvey, et al.. (1998). Research News. Nature Biotechnology. 16(2). 124–124. 1 indexed citations
4.
Bialy, Harvey. (1998). A new look in North-South biopartnerships. Nature Biotechnology. 16(11). 986–986. 7 indexed citations
5.
Papadimitriou, J. M., et al.. (1995). AIDS in Africa: distinguishing fact and fiction. World Journal of Microbiology and Biotechnology. 11(2). 135–143. 8 indexed citations
6.
Bialy, Harvey. (1991). Transgenic Pharming Comes of Age. Nature Biotechnology. 9(9). 786–788. 7 indexed citations
7.
Bialy, Harvey. (1990). Can Antibodies to IgE Act as Anti-Allergics?. Nature Biotechnology. 8(2). 96–96. 4 indexed citations
8.
Bialy, Harvey. (1989). Genome Technology: What Will It All Mean?. Nature Biotechnology. 7(7). 639–649. 1 indexed citations
9.
Bialy, Harvey. (1988). Epidermal Growth Factor: Anti-Tumoral Too?. Nature Biotechnology. 6(9). 997–997. 2 indexed citations
10.
Bialy, Harvey. (1988). Where is the Virus? And Where is the Press?. Nature Biotechnology. 6(2). 121–121. 1 indexed citations
11.
Bialy, Harvey. (1987). The Real Problems with Protein Design. Nature Biotechnology. 5(4). 332–332. 2 indexed citations
12.
Bialy, Harvey. (1987). Molecular Cardiology: The Beat Goes On. Nature Biotechnology. 5(6). 547–547. 1 indexed citations
13.
Bialy, Harvey. (1987). Cuba to Market an Ultra–Micro–ELISA System. Nature Biotechnology. 5(7). 663–663. 1 indexed citations
14.
Bialy, Harvey. (1986). Cuban Biotechnology: Interferon as a Model. Nature Biotechnology. 4(4). 265–266. 8 indexed citations
15.
Bialy, Harvey. (1986). Illustrated Biotechnologies. Bio/Technology. 4(11). 972–972. 2 indexed citations
16.
Bialy, Harvey. (1985). Genetic Engineering in the Precambrian. Nature Biotechnology. 3(6). 516–516. 2 indexed citations
17.
Bialy, Harvey. (1984). The Molecular Biology of Cancer. Nature Biotechnology. 2(10). 848–848. 1 indexed citations
18.
Bialy, Harvey, et al.. (1982). Transferable drug resistance in Pseudomonas patients with premature rupture of membranes in Ile-Ife, Nigeria.. PubMed. 9(1-2). 49–51. 1 indexed citations
19.
Bialy, Harvey, B. Waggoner, & Martin L. Pato. (1980). Fate of plasmids containing Mu DNA: Chromosome association and mobilization. Molecular and General Genetics MGG. 180(2). 377–383. 10 indexed citations
20.
Bialy, Harvey & Clarence Colby. (1972). Inhibition of Early Vaccinia Virus Ribonucleic Acid Synthesis in Interferon-Treated Chicken Embryo Fibroblasts. Journal of Virology. 9(2). 286–289. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026